Intellia Therapeutics (NTLA) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Next
Next
-1.02
-0.99
-0.95
-0.92

Details

Expected EPS
-0.960229
Actual EPS
N/A
Surprise EPS
0.96
Surprise Percent
+100%

Description

Intellia Therapeutics (NTLA) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts